Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04703686
Title Treatment by a Bispecific CD3xCD20 Antibody for Relapse/Refractory Lymphomas After CAR T-cells Therapy
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors The Lymphoma Academic Research Organisation
Age Groups: adult | senior
Covered Countries FRA

Facility Status City State Zip Country Details
CHU de Clermont Ferrand Recruiting Clermont Ferrand 63000 France Details
Hopital Henri Mondor Recruiting Créteil 94010 France Details
CHU de Dijon - Hôpital le Bocage Recruiting Dijon 21034 France Details
CHRU Lille - Hôpital Claude Huriez Recruiting Lille 59037 France Details
CHU Montpellier Recruiting Montpellier 34295 France Details
CHU Nantes Recruiting Nantes 44093 France Details
Hôpital Saint Louis Recruiting Paris 75475 France Details
APHP - Hôpital de la Pitiè Salpetrière Recruiting Paris France Details
APHP - Hôpital Saint Antoine Recruiting Paris France Details
CHU de Bordeaux - Hôpital Haut Leveque Recruiting Pessac 33604 France Details
CHU Lyon Sud Recruiting Pierre Bénite 69130 France Details
CHU de Rennes - Hôpital Pontchaillou Recruiting Rennes 35033 France Details
Centre Henri Becquerel Recruiting Rouen 76038 France Details
IUCT Oncopole Recruiting Toulouse 31059 France Details
CHU de Brabois Recruiting Vandoeuvre les Nancy France Details
*Shaded cells indicate that there was no data available from for the field